BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 21530327)

  • 1. B7-h2 is a costimulatory ligand for CD28 in human.
    Yao S; Zhu Y; Zhu G; Augustine M; Zheng L; Goode DJ; Broadwater M; Ruff W; Flies S; Xu H; Flies D; Luo L; Wang S; Chen L
    Immunity; 2011 May; 34(5):729-40. PubMed ID: 21530327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting T cell costimulation in autoimmune disease.
    Stuart RW; Racke MK
    Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.
    Li J; Semple K; Suh WK; Liu C; Chen F; Blazar BR; Yu XZ
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):962-9. PubMed ID: 21447398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable in vivo efficacy of CD28/B7, ICOS/GL50, and ICOS/GL50B costimulatory pathways in murine tumor models: IFNgamma-dependent enhancement of CTL priming, effector functions, and tumor specific memory CTL.
    Zuberek K; Ling V; Wu P; Ma HL; Leonard JP; Collins M; Dunussi-Joannopoulos K
    Cell Immunol; 2003 Sep; 225(1):53-63. PubMed ID: 14643304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of B7-dependent responses in CD28-deficient mice.
    Green JM; Noel PJ; Sperling AI; Walunas TL; Gray GS; Bluestone JA; Thompson CB
    Immunity; 1994 Sep; 1(6):501-8. PubMed ID: 7534617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
    J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
    Carreno BM; Collins M
    Annu Rev Immunol; 2002; 20():29-53. PubMed ID: 11861596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
    Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
    J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
    Koulova L; Clark EA; Shu G; Dupont B
    J Exp Med; 1991 Mar; 173(3):759-62. PubMed ID: 1847724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4.
    Chen L; Ashe S; Brady WA; Hellström I; Hellström KE; Ledbetter JA; McGowan P; Linsley PS
    Cell; 1992 Dec; 71(7):1093-102. PubMed ID: 1335364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cells: A proliferation of costimulatory molecules.
    Mueller DL
    Curr Biol; 2000 Mar; 10(6):R227-30. PubMed ID: 10744968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of inducible costimulator-ligand splice variants: lymphoid regulation of mouse GL50-B and human GL50 molecules.
    Ling V; Wu PW; Miyashiro JS; Marusic S; Finnerty HF; Collins M
    J Immunol; 2001 Jun; 166(12):7300-8. PubMed ID: 11390480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses.
    Wang S; Chen L
    Microbes Infect; 2004 Jul; 6(8):759-66. PubMed ID: 15207823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
    Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
    J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28-independent costimulation of T cells in alloimmune responses.
    Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH
    J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of costimulation.
    Sharpe AH
    Immunol Rev; 2009 May; 229(1):5-11. PubMed ID: 19426211
    [No Abstract]   [Full Text] [Related]  

  • 17. CD28/B7 costimulation: a review.
    Greenfield EA; Nguyen KA; Kuchroo VK
    Crit Rev Immunol; 1998; 18(5):389-418. PubMed ID: 9784967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS.
    Wang S; Zhu G; Chapoval AI; Dong H; Tamada K; Ni J; Chen L
    Blood; 2000 Oct; 96(8):2808-13. PubMed ID: 11023515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute graft-versus-host disease without costimulation via CD28.
    Speiser DE; Bachmann MF; Shahinian A; Mak TW; Ohashi PS
    Transplantation; 1997 Apr; 63(7):1042-4. PubMed ID: 9112366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Linsley PS
    J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.